Literature DB >> 12824274

Brain and retinal vascular endothelial cells with extended life span established by ectopic expression of telomerase.

Xiaolin Gu1, Jing Zhang, Darrell W Brann, Fu-Shin X Yu.   

Abstract

PURPOSE: To study blood-retina barrier (BRB) regulation, we sought to establish neuronal microvascular endothelial cells (ECs) with expanded life span by ectopic expression of the human telomerase gene (hTERT).
METHODS: Primary cultures of human brain and bovine retinal microvascular endothelial cells (HBECs and BRECs, respectively) were transfected with the catalytic component of human telomerase human telomerase reverse transcriptase (hTERT), and colonies were selected with puromycin. The endothelial origin of these cells was confirmed by immunocytochemistry. Reconstituted basement membrane matrix and three-dimensional collagen gel were used to induce the formation of tubulelike structures. To assess endothelial permeability, ECs were cultured on the upper chamber of migration assay membrane filters, with or without astrocyte coculture. Transepithelial electrical resistance (TER) was measured using a voltohmmeter.
RESULTS: Both bovine retinal and human brain microvascular ECs expressing hTERT resembled young primary ECs in their morphology and growth response after more than 100 population doublings. Both bovine and human hTERT cells expressed von Willebrand factor, a key marker distinguishing ECs from other cell types; formed angiogenic webs in reconstituted basement membrane matrix; and, in a VEGF-dependent manner, formed tubule-like structures in three-dimensional collagen gel. Coculture of both types of cells with astrocytes resulted in a decrease in EC permeability, as assessed by TER. VEGF induced the breakdown of the HBEC monolayer barrier, and astrocytes in coculture appeared to attenuate the effects of VEGF.
CONCLUSIONS: Ectopic expression of hTERT enables adult HBECs to bypass the first mortality checkpoint but not the second mortality checkpoint, allowing generation of neuronal ECs with extended, but not indefinite life span.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824274     DOI: 10.1167/ivos.02-0852

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

Review 1.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 2.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

3.  Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans.

Authors:  Kiem Vu; Babette Weksler; Ignacio Romero; Pierre-Olivier Couraud; Angie Gelli
Journal:  Eukaryot Cell       Date:  2009-09-18

4.  CXCL10 suppression of hem- and lymph-angiogenesis in inflamed corneas through MMP13.

Authors:  Nan Gao; Xiaowei Liu; Jiayin Wu; Juan Li; Chen Dong; Xinyi Wu; Xiao Xiao; Fu-Shin X Yu
Journal:  Angiogenesis       Date:  2017-06-16       Impact factor: 9.596

5.  Relevance and safety of telomerase for human tissue engineering.

Authors:  Rebecca Y Klinger; Juliana L Blum; Bevin Hearn; Benjamin Lebow; Laura E Niklason
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

6.  ATP-binding cassette transporters in immortalised human brain microvascular endothelial cells in normal and hypoxic conditions.

Authors:  Christian Lindner; Alexander Sigrüner; Franziska Walther; Ulrich Bogdahn; Pierre O Couraud; Gert Schmitz; Felix Schlachetzki
Journal:  Exp Transl Stroke Med       Date:  2012-05-03

Review 7.  Modeling human endothelial cell transformation in vascular neoplasias.

Authors:  Victoria W Wen; Karen L MacKenzie
Journal:  Dis Model Mech       Date:  2013-09       Impact factor: 5.758

Review 8.  Therapeutic Targeting of Telomerase.

Authors:  Kathrin Jäger; Michael Walter
Journal:  Genes (Basel)       Date:  2016-07-21       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.